SOX5 binds to the promoter regions of ZO-1 (Zonula Occludens-1), occluding, and claudin-5 and regulates the expression of tight junction proteins in GECs, thus controlling the permeability of the blood–tumor barrier (BTB), the limiting factor for drug delivery in glioma treatments [78]. Here, SOX5 is linked to glioma.